scholarly article | Q13442814 |
P50 | author | Martin Schrappe | Q66385545 |
P2093 | author name string | H. Phillip Koeffler | |
Claus R. Bartram | |||
Martin Zimmermann | |||
Takayuki Ikezoe | |||
Naoki Komatsu | |||
Seisho Takeuchi | |||
Taku Seriu | |||
Masahide Matsushita | |||
P2860 | cites work | Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 |
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor | Q28217975 | ||
DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia | Q33183927 | ||
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia | Q33185818 | ||
Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. | Q34327110 | ||
Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia | Q38303652 | ||
Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup. | Q38350481 | ||
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. | Q39975102 | ||
Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia | Q44802872 | ||
RARbeta2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia | Q45054546 | ||
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia | Q46398603 | ||
The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. | Q47295374 | ||
DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia | Q51920992 | ||
Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. | Q54713341 | ||
Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia. | Q54762871 | ||
Acute lymphoblastic leukaemia | Q56722375 | ||
Aberrant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance | Q73754614 | ||
CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia | Q80129003 | ||
Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia | Q80416837 | ||
Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia | Q81453481 | ||
Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome | Q83318087 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA methylation | Q874745 |
precursor B-cell lymphoblastic leukemia | Q5973974 | ||
precursor T-cell lymphoblastic leukemia | Q7239590 | ||
lymphoblastic leukemia | Q18553852 | ||
P304 | page(s) | 1345-1349 | |
P577 | publication date | 2011-05-17 | |
P1433 | published in | Leukemia Research | Q15716445 |
P1476 | title | Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia | |
P478 | volume | 35 |
Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
Q39958090 | DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia |
Q37055329 | DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia |
Q53544854 | DNA methylation patterns in EBV-positive and EBV-negative Hodgkin lymphomas |
Q43004456 | DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study |
Q38141135 | Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia |
Q38297582 | Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways |
Q38168688 | Evaluating DAPK as a therapeutic target. |
Q33427040 | Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia |
Q37627410 | Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia |
Q47138733 | MGMT promoter methylation as a potential prognostic marker for acute leukemia |
Q38097334 | Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions |
Q53379155 | Promoter methylation and expression of death-associated protein kinase gene in acute leukemia |
Q36990438 | The epigenome as a potential mediator of cancer and disease prevention in prenatal development |
Q47097037 | Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL). |
Q55492703 | [The Role of SOCS in the Development of Tumors]. |